Lorcaserin was used long term for weight loss in those who are obese. Lorcaserin was developed by Arena Pharmaceuticals Inc..
The API has now reached off-patent status, after being launched in 2012.

The information provided above is sourced from Chemrobotics PharmaVetPat https://chemroboticspharma.com/pharmVetPat
to find out more, including patent landscape and routes of synthesis, please contact our sales team.

For enquiries regarding more detailed trade data of Lorcaserin and many others, contact info@pharmacheminvestor.com